KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Other Operating Expenses (2018 - 2025)

Historic Other Operating Expenses for Emergent BioSolutions (EBS) over the last 10 years, with Q1 2025 value amounting to -$12.2 million.

  • Emergent BioSolutions' Other Operating Expenses changed N/A to -$12.2 million in Q1 2025 from the same period last year, while for Sep 2025 it was -$12.2 million, marking a year-over-year decrease of 15020.58%. This contributed to the annual value of $24.3 million for FY2024, which is 6725.07% down from last year.
  • According to the latest figures from Q1 2025, Emergent BioSolutions' Other Operating Expenses is -$12.2 million.
  • In the past 5 years, Emergent BioSolutions' Other Operating Expenses registered a high of $305.2 million during Q4 2021, and its lowest value of -$40.0 million during Q2 2024.
  • In the last 5 years, Emergent BioSolutions' Other Operating Expenses had a median value of $114.2 million in 2021 and averaged $120.0 million.
  • Examining YoY changes over the last 5 years, Emergent BioSolutions' Other Operating Expenses showed a top increase of 928571.43% in 2024 and a maximum decrease of 15340.45% in 2024.
  • Quarter analysis of 5 years shows Emergent BioSolutions' Other Operating Expenses stood at $305.2 million in 2021, then tumbled by 44.33% to $169.9 million in 2022, then plummeted by 100.41% to -$700000.0 in 2023, then skyrocketed by 9285.71% to $64.3 million in 2024, then tumbled by 118.97% to -$12.2 million in 2025.
  • Its Other Operating Expenses was -$12.2 million in Q1 2025, compared to $64.3 million in Q3 2024 and -$40.0 million in Q2 2024.